Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics to modify ...
Live Science on MSN
New drug could prevent diabetes complications not fixed with blood sugar control, study hints
An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback